Last reviewed · How we verify
Pieceid (polydatin)
At a glance
| Generic name | polydatin |
|---|---|
| Drug class | pieceid |
| Target | Glucose-6-phosphate 1-dehydrogenase, Aldose reductase |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome (NA)
- EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS) (NA)
- Effectiveness of Curcumin-based Food Supplement in Reducing Pain and Inflammatory Component in Osteoarthritis (NA)
- Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis (NA)
- Polydatin Injectable (HW6) for Shock Treatment (PHASE2)
- Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pieceid CI brief — competitive landscape report
- Pieceid updates RSS · CI watch RSS
- portfolio CI